Published in J Clin Microbiol on August 01, 1984
What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev (2002) 5.81
Applications of cellular fatty acid analysis. Clin Microbiol Rev (1991) 2.72
Classification and identification of the viridans streptococci. Clin Microbiol Rev (1989) 2.70
Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol (1989) 2.43
Occurrence of Streptococcus milleri among beta-hemolytic streptococci isolated from clinical specimens. J Clin Microbiol (1985) 1.64
Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis (2005) 1.46
Measurement of active constitutive beta-D-glucosidase (esculinase) in the presence of sodium desoxycholate. J Clin Microbiol (1985) 1.30
Neonatal sepsis caused by Streptococcus bovis variant (biotype II/2): report of a case and review. J Clin Microbiol (2003) 1.07
Accuracy and reproducibility of the IDS rapID STR system for species identification of streptococci. J Clin Microbiol (1986) 1.06
A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma. J Clin Pathol (1998) 0.94
Biochemical and antigenic properties of Streptococcus bovis isolated from pigeons. J Clin Microbiol (1992) 0.90
Identification of Streptococcus bovis biotype I strains among S. bovis clinical isolates by PCR. J Clin Microbiol (2002) 0.79
Inflammatory bowel disease and Streptococcus bovis. Dig Dis Sci (2006) 0.76
Rapid identification of Streptococcus bovis by using combination constitutive enzyme substrate hydrolyses. J Clin Microbiol (1989) 0.76
THE STREPTOCOCCI. Bacteriol Rev (1937) 28.71
Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol (1972) 13.09
Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17
Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23
Further Studies on Urease Production by Proteus and Related Organisms. J Bacteriol (1945) 7.31
Streptococcus salivarius and Other Non-hemolytic Streptococci of the Human Throat. J Bacteriol (1943) 6.85
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
Presumptive speciation of Streptococcus bovis and other group D streptococci from human sources by using arginine and pyruvate tests. J Clin Microbiol (1975) 4.27
Identification of streptococci: use of lysozyme and Streptomyces albus filtrate in the preparation of extracts for Lancefield grouping. J Clin Microbiol (1975) 3.53
Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06
Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95
Antigens of Streptococcus sanguis. Infect Immun (1973) 2.89
The influence of the growth medium on the demonstration of a group D antigen in faecal streptococci. J Gen Microbiol (1962) 2.85
Comparison of rapid methods for analysis of bacterial fatty acids. Appl Microbiol (1974) 2.63
Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med (1978) 2.54
Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci. Am J Med (1974) 2.39
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
Association of Streptococcus bovis bacteremia with bowel disease. J Clin Microbiol (1983) 2.01
Nonenterococcal group-D streptococcal endocarditis caused by Streptococcus bovis. Ann Intern Med (1974) 1.74
Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infectious due to Streptococcus bovis. N Engl J Med (1973) 1.53
Differentiation of some enterococci by gas chromatography. J Bacteriol (1973) 1.29
Evaluation of slide agglutination methods for identifying group D streptococci. J Clin Microbiol (1983) 1.20
Humoral reactions in human endocarditis due to Streptococcus bovis: evidence for a common S bovis antigen. J Infect Dis (1983) 1.01
Cellular fatty acid composition of Streptococcus mutans and related streptococci. J Dent Res (1976) 0.98
Identification of group D streptococci by SeroSTAT. J Clin Microbiol (1982) 0.90
Streptococcus bovis endocarditis. Am J Med (1974) 0.90
Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet (2001) 5.90
Species identities of enterococci isolated from clinical specimens. J Clin Microbiol (1990) 4.54
How far to go with Enterobacteriaceae? J Infect Dis (1969) 4.10
Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies. Medicine (Baltimore) (1977) 4.05
Biochemical differentiation of the Enterobacteriaceae with the aid of lysine-iron-agar. Appl Microbiol (1966) 3.96
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob Agents Chemother (2004) 3.82
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrob Agents Chemother (1993) 3.80
Identification of streptococci: use of lysozyme and Streptomyces albus filtrate in the preparation of extracts for Lancefield grouping. J Clin Microbiol (1975) 3.53
Extrarespiratory streptococcal infections. Importance of the various serologic groups. N Engl J Med (1966) 3.50
Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin. Antimicrob Agents Chemother (1977) 3.27
Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16
Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (2008) 3.13
Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med (1970) 3.08
Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother (1991) 3.00
Automated identification of gram-positive bacteria. J Clin Microbiol (1982) 2.94
Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob Agents Chemother (2000) 2.80
Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol (1994) 2.77
Vancomycin-resistant gram-positive bacteria isolated from human sources. J Clin Microbiol (1988) 2.71
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob Agents Chemother (1999) 2.49
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol (1994) 2.47
Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol (1994) 2.44
Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol (1989) 2.43
Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci. Am J Med (1974) 2.39
Antibiotic synergism against Listeria monocytogenes. Antimicrob Agents Chemother (1972) 2.36
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother (1993) 2.29
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother (1996) 2.22
Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev (2001) 2.19
Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol (2001) 2.16
Helcococcus, a new genus of catalase-negative, gram-positive cocci isolated from clinical specimens. J Clin Microbiol (1995) 2.15
Simplified storage and retrieval of stock cultures. Appl Microbiol (1972) 2.12
Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria. Am J Med (1977) 2.07
Use of the Rapid STREP system for identification of viridans streptococcal species. J Clin Microbiol (1983) 2.02
Nucleotide binding and cofactor activities of purified bovine brain and bacterially expressed ADP-ribosylation factor. J Biol Chem (1989) 2.00
Carmine as a source of nosocomial salmonellosis. N Engl J Med (1967) 1.98
Identification of viridans streptococci isolated from clinical specimens. J Clin Microbiol (1982) 1.98
Genitourinary tuberculosis. Clinical features in a general hospital population. Am J Med (1977) 1.91
The so-called "Paracolon" bacteria. A bacteriologic and clinical reappraisal. Am J Med (1967) 1.88
Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (2003) 1.88
Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin. Antimicrob Agents Chemother (1974) 1.86
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci. J Clin Microbiol (1992) 1.79
Neurotoxicity of glucocorticoids in the primate brain. Horm Behav (1994) 1.79
Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol (1994) 1.78
Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits. J Clin Microbiol (1992) 1.76
Comparison of Vibrio cholerae O139 with V. cholerae O1 classical and El Tor biotypes. Infect Immun (1994) 1.76
Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns. Antimicrob Agents Chemother (1983) 1.74
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent. Antimicrob Agents Chemother (1990) 1.71
New cause for false-positive results with the cryptococcal antigen test by latex agglutination. J Clin Microbiol (1985) 1.70
"Streptococcus milleri" strains displaying a gliding type of motility. Int J Syst Bacteriol (1995) 1.70
Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab (1995) 1.66
Occurrence of Streptococcus milleri among beta-hemolytic streptococci isolated from clinical specimens. J Clin Microbiol (1985) 1.64
Listeriosis in humans: an evaluation. J Infect Dis (1971) 1.63
Routine identification of yeasts with the aid of molybdate-agar medium. Appl Microbiol (1968) 1.57
Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys (2001) 1.53
Colonization of skin by Helcococcus kunzii. J Clin Microbiol (1997) 1.51
Identification of "Streptococcus milleri" group isolates to the species level with a commercially available rapid test system. J Clin Microbiol (1995) 1.48
Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol (1994) 1.47
Analysis of tRNAs during the development of Drosophila. Dev Biol (1973) 1.46
Performance of the Abbott RealTime CT/NG for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2010) 1.45
Fetal haemorrhagic lesions after chorionic villous sampling. Lancet (1992) 1.43
Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg Am (1990) 1.37
Catheter-associated infection with a vancomycin-resistant gram-positive coccus of the Leuconostoc sp. Pediatr Infect Dis J (1988) 1.36
Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance. Antimicrob Agents Chemother (1991) 1.35
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.34
The residues of Ras and Rap proteins that determine their GAP specificities. J Biol Chem (1991) 1.33
In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother (1993) 1.33
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol (1993) 1.33
Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol (1984) 1.32
Accurate automated identification of selected Enterobacteriaceae at four hours. J Clin Microbiol (1981) 1.32
Value of stool cultures. Lancet (1980) 1.26
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25
Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis (1989) 1.23
Infectious crystalline keratopathy. Role of nutritionally variant streptococci and other bacterial factors. Ophthalmology (1991) 1.23
A duplication in the L1CAM gene associated with X-linked hydrocephalus. Nat Genet (1993) 1.22
Susceptibilities of Legionella spp. to newer antimicrobials in vitro. Antimicrob Agents Chemother (1998) 1.22
THE ACTION OF GROWTH INHIBITORS ON CARBOHYDRATE METABOLISM IN THE PEA. Plant Physiol (1949) 1.21
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis (1993) 1.21
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
Report of cases of and taxonomic considerations for large-colony-forming Lancefield group C streptococcal bacteremia. J Clin Microbiol (1995) 1.20
Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent. Antimicrob Agents Chemother (1989) 1.19
High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother (2005) 1.19
Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards. J Clin Microbiol (1991) 1.19
In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria. Antimicrob Agents Chemother (1989) 1.16
Mechanical method of inoculating plates for antibiotic sensitivity testing. Appl Microbiol (1971) 1.16
Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. J Clin Microbiol (1995) 1.15
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. Am J Pathol (2000) 1.15
Vibrotactile amplitude discrimination capacity parallels magnitude changes in somatosensory cortex and follows Weber's Law. Exp Brain Res (2008) 1.14
Cefuroxime screening test for pneumococci. J Clin Microbiol (1993) 1.14
Simple microbiologic detection of Campylobacter pylori. J Clin Microbiol (1988) 1.13
Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med (1990) 1.13